Secondary prevention and referral of elderly patients to a cardiovascular lipid service

scientific article published on 01 July 1999

Secondary prevention and referral of elderly patients to a cardiovascular lipid service is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0167-4943(99)00014-X
P698PubMed publication ID15374072

P50authorHapizah M. NawawiQ59205440
P2093author name stringG Hamilton
A Winder
L Day
D Mikhailis
P2860cites workPrevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study GroupQ29619842
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsQ29620696
Usual care dietary practice, achievement and implications for medication in the management of hypercholesterolaemia. Data from the U.K. Lipid Clinics ProgrammeQ31989427
Total cholesterol and risk of mortality in the oldest old.Q34443709
Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo studyQ36779054
Value of screening for secondary causes of hyperlipidaemia in general practiceQ36890609
Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic diseaseQ37216450
Hypercholesterolemia in elderly persons: resolving the treatment dilemmaQ37918742
Risk factor modification trials: implications for the elderlyQ39645272
Management of older adults with hypercholesterolaemiaQ40679542
Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literatureQ40904739
Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?Q43890386
Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994.Q46246864
Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo StudyQ46659891
Beneficial effects of pravastatin on fasting hyperinsulinemia in elderly hypertensive hypercholesterolemic subjects.Q51579374
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.Q52230212
Fibrinogen and risk of cardiovascular disease. The Framingham Study.Q52588834
Seasonal changes in haemostatic factors in young and elderly subjectsQ57134599
Screening for Coronary Heart Disease Risk in the Elderly: Total Cholesterol Versus High-Density Lipoprotein—CholesterolQ67856624
Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populationsQ67900775
Quantitative and qualitative alterations of acute-phase proteins in healthy elderly personsQ71160606
Lipoprotein(a) and peripheral atherosclerosis in older adultsQ71303709
Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries StudyQ72325389
Pravastatin experience in elderly and non-elderly patientsQ72547650
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)Q73994857
Lipids and stroke: neglect of a useful preventive measure?Q77809481
P433issue1
P304page(s)1-11
P577publication date1999-07-01
P1433published inArchives of Gerontology and GeriatricsQ15749513
P1476titleSecondary prevention and referral of elderly patients to a cardiovascular lipid service
P478volume29

Search more.